drug · small molecule
TTI-101
Phase 2updated 3mo agoby $TVRD Tvardi Therapeutics, Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying TTI-101
- phase2Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
- phase1Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
- phase2A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- phase1Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
- phase1Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that